Pharmaceutical

Suven Pharmaceuticals to gain controlling stake in Sapala Organics

India-based Suven Pharmaceuticals has announced a definitive agreement to acquire a strategic controlling stake in Sapala Organics.

Jun 16, 2024 - 04:00
Suven Pharmaceuticals to gain controlling stake in Sapala Organics
India-based Suven Pharmaceuticals has announced a definitive agreement to acquire a strategic controlling stake in Sapala Organics.
Read the original article

Tags:

Previous Article

Santa Ana Bio secures $168m for inflammatory disease treatments

Next Article

AbbVie and FutureGen link on inflammatory bowel disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys

STAT+: A looming cancer vaccine test for Gritstone Bio,...

Feb 9, 2024

STAT+: San Diego biotech Neurocrine Biosciences joins PhRMA

STAT+: San Diego biotech Neurocrine Biosciences joins P...

Feb 23, 2024

Laurus Labs and IIT Kanpur partner for new gene therapy products

Laurus Labs and IIT Kanpur partner for new gene therapy...

Jun 19, 2023